|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BRADLEY PHARMACEUTICALS INC, 10QSB, EX-1, 2000-11-14 |
Next: CYBERONICS INC, 10-Q, 2000-11-14 |
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
Balance Sheet, Cash Flow and Statement of Operations and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-END> SEP-30-2000
<CASH> 187,643
<SECURITIES> 0
<RECEIVABLES> 4,298,545
<INVENTORY> 2,479,040
<CURRENT-ASSETS> 7,454,884
<PP&E> 1,125,790
<DEPRECIATION> 904,699
<TOTAL-ASSETS> 16,130,193
<CURRENT-LIABILITIES> 5,523,989
<LT DEBT> 741,128
0
0
<COMMON> 15,620,218
<OTHER-SE> (5,755,142)
<TOTAL-LIABILITY-AND-EQUITY> 16,130,193
<SALES> 11,556,819
<TOTAL-REVENUES> 11,556,819
<CGS> 2,915,107
<TOTAL-COSTS> 2,915,107
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 182,167
<INCOME-PRETAX> (4,248,705)
<INCOME-TAX> (137,000)
<INCOME-CONTINUING> (4,111,705)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,111,705)
<EPS-BASIC> (0.52)
<EPS-DILUTED> (0.52)
</TABLE>
|
|